12th Nov 2015 11:35
LONDON (Alliance News) - Respiratory drug development company Synairgen PLC on Thursday said four of its directors bought 163,000 shares in the business on Wednesday, all at 23.00 pence per share.
Chief Executive Richard Marsden bought 43,460 shares, giving him a total holding of 154,432 shares, or a 0.17% stake.
Finance Director John Ward bought 32,594 shares, taking his holding up to 276,506 shares, or a 0.3% stake.
Chief Scientific Officer Philip Monk bought 21,729 shares for a total of 183,439 shares, or 0.2% of the share capital.
And Chairman Simon Shaw bought 65,217 shares, taking his total stake up to 1.6%, or 1.5 million shares.
Synairgen shares were up 11% to 26.00p on Thursday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Synairgen